Elite in Nevoid Basal Cell Carcinoma Syndrome

John T. Lear

Manchester, ENG, GB 
Elite in Nevoid Basal Cell Carcinoma Syndrome
Manchester, ENG, GB 
OverviewLocationsClinical Research

Overview

John Lear practices in Manchester, United Kingdom. Mr. Lear is rated as an Elite expert by MediFind in the treatment of Nevoid Basal Cell Carcinoma Syndrome. His top areas of expertise are Basal Cell Skin Cancer, Nevoid Basal Cell Carcinoma Syndrome, Actinic Keratosis, and Squamous Cell Skin Carcinoma.

His clinical research consists of co-authoring 75 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 9 articles and participated in 1 clinical trial in the study of Nevoid Basal Cell Carcinoma Syndrome.

Gender
Male

Locations

Manchester, ENG, United Kingdom
Other Locations
Salford, ENG, United Kingdom
Cambridge, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Effect of Calcipotriol Plus Betamethasone Dipropionate Gel on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to 16 Years, 11 Months) With Scalp and Body Psoriasis
Effect of Calcipotriol Plus Betamethasone Dipropionate Gel on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to 16 Years, 11 Months) With Scalp and Body Psoriasis
Enrollment Status: Completed
Publish Date: March 10, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Randomized, Double-blind, Vehicle-controlled, Phase 3 Efficacy and Safety Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome
A Multicenter, Randomized, Double-blind, Vehicle-controlled, Phase 3 Efficacy and Safety Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome
Enrollment Status: Completed
Publish Date: July 03, 2024
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

75 Total Publications

Metastatic basal cell carcinomas in Gorlin syndrome-A case series and literature review.
Metastatic basal cell carcinomas in Gorlin syndrome-A case series and literature review.
Journal: The Australasian journal of dermatology
Published: August 07, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Lear's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile